Lys Medical key facts
as of Oct 2026- Developer of precision measuring systems designed to be used for endoscopies.
- Lys Medical is valued at approximately $5.9M as of Oct 2026 (last reported valuation).
- It has raised $4.3M; the latest was Later Stage VC ($3.7M) in Jun 2025.
- Notable investors include SambrInvest, Université Libre de Bruxelles.
- Status: Privately Held (backing).
Lys Medical's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·Watch Lys Medical: the Monday email on marks, rounds and moves
Lys Medical funding rounds
No funding rounds for Lys Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Lys Medical
2Lys Medical valuation
Lys Medical's last reported valuation was $5.9 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
Lys Medical investors
2 investors are on record for Lys Medical, including SambrInvest and Université Libre de Bruxelles.
About Lys Medical
Developer of precision measuring systems designed to be used for endoscopies. The company's system quantifies the size of an obstruction in the bronchi and diagnoses peripheral nodules with positive predictive value, enabling pulmonologists to provide cost-effective diagnostic and treatment processes to their patients.
- Sector
- Healthcare
- HQ
- Charleroi, Belgium
- Founded
- 2018
- Employees
- 11
- Website
- lysmedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.